The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radioembolization with chemotherapy for liver-dominant colorectal cancer: Analysis of patient subgroups in the EPOCH trial.
 
William Proctor Harris
Consulting or Advisory Role - BD Medical; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Merck; Neo Therma; QED therapeutics; Zymeworks
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Exelixis (Inst); Halozyme (Inst); Koo Foundation (Inst); MedImmune (Inst); Merck (Inst); zymeworks (Inst)
Travel, Accommodations, Expenses - Eisai
 
Mary Frances Mulcahy
Honoraria - Boston Scientific
Consulting or Advisory Role - Boston Scientific
Research Funding - BTG
 
Riad Salem
Consulting or Advisory Role - AstraZeneca; Bard Medical; Boston Scientific; Cook Medical; Eisai; Genentech/Roche; QED Therapeutics; Siemens; Sirtex Medical
Research Funding - Boston Scientific (Inst)